FDA backtracks and agrees to review Moderna mRNA flu vaccine after initial rejection

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot. Moderna announced the change Wednesday, about a week ...

🔗 Read more: https://fortune.com/2026/02/18/fda-backtracks-and-agrees-to-review-moderna-mrna-flu-vaccine-after-initial-rejection/

#News #Medicine #Tech #Software #Business #Health